These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Immunopathological aspects of age-related macular degeneration. Patel M; Chan CC Semin Immunopathol; 2008 Apr; 30(2):97-110. PubMed ID: 18299834 [TBL] [Abstract][Full Text] [Related]
33. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration. Bora NS; Matta B; Lyzogubov VV; Bora PS Mol Immunol; 2015 Feb; 63(2):176-83. PubMed ID: 25074023 [TBL] [Abstract][Full Text] [Related]
34. Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. Cheung CM; Wong TY J Intern Med; 2014 Aug; 276(2):140-53. PubMed ID: 24581182 [TBL] [Abstract][Full Text] [Related]
36. Inflammatory biomarkers for AMD. Stanton CM; Wright AF Adv Exp Med Biol; 2014; 801():251-7. PubMed ID: 24664705 [TBL] [Abstract][Full Text] [Related]
37. Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration. Cooke Bailey JN; Pericak-Vance MA; Haines JL Cold Spring Harb Perspect Med; 2014 Sep; 4(12):a017186. PubMed ID: 25213188 [TBL] [Abstract][Full Text] [Related]
38. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment. Geerlings MJ; de Jong EK; den Hollander AI Mol Immunol; 2017 Apr; 84():65-76. PubMed ID: 27939104 [TBL] [Abstract][Full Text] [Related]